TREATMENT OF C-MYC/BCL2 DOUBLE EXPRESSER DLBCL WITH R-CHOP CHEMOIMMUNOTHERAPY: AN AUSTRALIAN SINGLE CENTRE EXPERIENCE

被引：0
|
作者：
Ng, T. F. [1 ,2 ]
Whiteside, A. [3 ]
Rose, H. [1 ]
Kipp, D. [1 ]
Tawfik, B. [3 ]
Campbell, P. [1 ,4 ]
机构：
[1] Univ Hosp Geelong, Clin Haematol, Geelong, Vic, Australia
[2] Fiona Stanley Hosp, Haematol, Perth, WA, Australia
[3] St John God Pathol, Anat Pathol, Geelong, Vic, Australia
[4] Deakin Univ, Sch Med, Geelong, Vic, Australia
来源：
HAEMATOLOGICA | 2016年 / 101卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PB1724
引用
收藏
页码：701 / 701
页数：1
相关论文
共 37 条
  • [31] RELATIVE TOTAL DOSE INTENSITY OF TREATMENT WITH R-CHOP IN OBESE VERSUS NON OBESE LYMPHOMA PATIENTS DOSED ON ACTUAL BODY WEIGHT: A SINGLE CENTRE EXPERIENCE
    Preston, A.
    Robinson, S.
    Mehta, P.
    Duncan, N.
    HAEMATOLOGICA, 2016, 101 : 701 - 702
  • [32] The role of translocations involving c-MYC/8q24, BCL2/18q21 and/or BCL6/3q27 genes in patients with follicular lymphoma. Retrospective analysis of single-centre data
    Misyurina, A. E.
    Kravchenko, S. K.
    Kovrigina, A. M.
    Magomedova, A. U.
    Plastinina, L., V
    Obukhova, T. N.
    Misyurin, A., V
    Misyurin, V. A.
    Grebenuk, L. A.
    Babaeva, F. E.
    Baryakh, E. A.
    Vorobiev, A., I
    TERAPEVTICHESKII ARKHIV, 2019, 91 (07) : 52 - 62
  • [33] Theraputic Approaches to High Grade B-Cell Lymphoma Double-Hit and Follicular Lymphoma with C - MYC, BCL2 and/or BCL6 rearrangements. Single Center Expirience
    Misyurina, Anna E.
    Kravchenko, Sergey K.
    Kovrigina, Alla M.
    Baryakh, Elena A.
    Plastinina, Lubov V.
    Magomedova, Aminat U.
    Obukhova, Tatiana N.
    Nesterova, Ekaterina S.
    Misyurin, Vsevolod A.
    Misyurin, Andrey V.
    Vorobiev, Andrey I.
    Babaeva, Fatima E.
    Savchenko, Valery
    BLOOD, 2017, 130
  • [34] Impact of C-MYC/BCL2 Double Expression on Survival Outcomes After Autologous Transplantation in Relapsed/Refractory Diffuse Large B Cell Lymphoma-A Nationwide Retrospective Analysis in Singapore
    Tan, Jing Yuan
    Ling, Victor Wei Teik
    Ng, Lawrence Cheng Kiat
    Krisnadi, Cindy
    Tan, Melinda Si Yuan
    Grigoropoulos, Nicholas Francis
    Ong, Shin Yeu
    Nagarajan, Chandramouli
    Quek, Jeffrey Kim Siang
    Than, Hein
    Lee, Joanne
    Chan, Esther
    Tan, Lip Kun
    Hwang, William Ying Khee
    Goh, Yeow Tee
    Linn, Yeh Ching
    Koh, Liang Piu
    Ho, Aloysius Yew Leng
    Lim, Francesca Wei Inng
    Poon, Michelle Limei
    Chen, Yunxin
    HEMATOLOGICAL ONCOLOGY, 2025, 43 (01)
  • [35] PROGNOSTIC INFLUENCE OF C-MYC, BCL2, PSTAT3 EXPRESSION, GCB/NON-GCB SUBTYPE ON TREATMENT RESULTS OF DIFFUSE LARGE B CELL LYMPHOMA IN CHILDREN AND ADOLESCENTS
    Levashov, A.
    Kovrigina, A.
    Valiev, T.
    Belyaeva, E.
    Popa, A.
    Mentkevich, G.
    PEDIATRIC BLOOD & CANCER, 2015, 62 : S315 - S316
  • [36] Young High Risk Patients with MYC/BCL2 Double Hit Lymphoma, BCL2+and/or Germinal Centre B-Cell like Diffuse Large B-Cell Lymphoma Benefit from Dose-Dense Chemoimmunotherapy Including Early CNS Prophylaxis: Analysis of Data from the Nordic Lymphoma Group CRY-04 and Chic Trials
    Leppa, Sirpa
    Jorgensen, Judit
    Meriranta, Leo
    Beiske, Klaus
    Delabie, Jan M. A.
    Ralfkiaer, Elisabeth
    Spetalen, Signe
    Karjalainen-Lindsberg, Marja-Liisa
    Holte, Harald
    BLOOD, 2018, 132
  • [37] Successful treatment of both double minute of C-MYC and BCL-2 rearrangement containing large B-cell lymphoma with subsequent unfortunate development of therapy-related acute myeloid leukemia with t(3;3)(q26.2;q21)
    Nguyen, John C.
    Kubik, Melanie J.
    Broome, H. Elizabeth
    Curtin, Peter T.
    Dell'Aquila, Marie L.
    Wang, Huan-You
    PATHOLOGY RESEARCH AND PRACTICE, 2015, 211 (11) : 883 - 891
1234